Program Schedule

PW5
Fellows' Day Workshop $

Wednesday, October 8, 2014: 8:00 AM-12:00 PM
Room: The Pennsylvania Convention Center: 114
ID Training Program Directors' Committee

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe key clinical factors relevant to forming a differential diagnosis for the presentation of a diverse variety of infectious diseases
  • identify the latest advances in diagnosis and treatment of hepatitis C
  • describe the management of hepatitis C in special populations
  • discuss challenging clinical scenarios that clinicians may encounter in their practice.

Target Audience: Members-in-training, Medical students and residents, Fellows

Tracks: Adult ID

Pre-Meeting Workshop Moderators:  Maximo Brito, MD, MPH, University of Illinois at Chicago and Rajesh Gandhi, MD, Massachusetts General Hospital

Pre-Meeting Workshop Panelists:  Maximo Brito, MD, MPH, University of Illinois at Chicago , Wendy Armstrong, MD, FIDSA, Emory University , Carlos Isada, MD, Cleveland Clinic and Stuart Cohen, MD, FIDSA, FSHEA, University of California, Davis Medical Center

Presentations:
8:00 AM
W32
HCV Introduction
Maximo Brito, MD, MPH
8:05 AM
W33
HCV Treatment
Mark Sulkowski, MD
8:30 AM
W34
HCV Initial Evaluation
Melissa Osborn, MD
9:00 AM
W35
HIV/HCV co-infection
Arthur Kim, MD, FIDSA
Presentations
  • Kim_HIV-HCV Co-Infection.pdf (6.3 MB)
  • 10:00 AM
    10:15 AM
    W37
    Pre-Meeting Workshop Panelist
    Maximo Brito, MD, MPH
    10:35 AM
    W38
    Pre-Meeting Workshop Panelist
    Wendy Armstrong, MD, FIDSA
    10:55 AM
    W39
    11:15 AM
    W40
    Pre-Meeting Workshop Panelist
    Stuart Cohen, MD, FIDSA, FSHEA

    CME Credits:

    ACPE Credits: No CPE credit is offered for this session.

    ACPE Number:

    Disclosures:

    M. Brito, None

    R. Gandhi, None

    M. Brito, None

    W. Armstrong, None

    C. Isada, None

    S. Cohen, None

    M. Osborn, Merck: Investigator, Research support

    M. T. Melia, None

    M. Sulkowski, AbbVie: Investigator and Scientific Advisor, Consulting fee and Research grant
    BMS: Investigator and Scientific Advisor, Consulting fee and Research support
    Gilead: Investigator and Scientific Advisor, Consulting fee and Research support
    Janssen: Investigator and Scientific Advisor, Consulting fee and Research support
    Merck: Investigator and Scientific Advisor, Consulting fee and Research support

    A. Kim, Gilead Sciences: Consultant and Investigator, Consulting fee and Research support
    Abbvie Pharmaceuticals, Inc.: Consultant, Consulting fee
    Bristol-Myers Squibb: Investigator, Research support

    M. Brito, None

    See more of: Premeeting Session

    Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

    Sponsoring Societies:

    © 2014, idweek.org. All Rights Reserved.

    Follow IDWeek